Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Biochem Pharmacol. 2013 Aug 5;86(6):824–835. doi: 10.1016/j.bcp.2013.07.023

Figure 5. Compounds 1, 2, 4, and 7 are PXR agonists.

Figure 5

HepG2 cells transiently transfected with hPXR, CYP3A4-luc, and CMV-Renilla were treated for 24 h with indicated concentrations of compounds prior to luciferase assay.